Literature DB >> 19615866

Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.

Yoichi Hirakata1, Akira Kondo, Kazuki Hoshino, Hisakazu Yano, Kazuaki Arai, Ayako Hirotani, Hiroyuki Kunishima, Natsuo Yamamoto, Masumitsu Hatta, Miho Kitagawa, Shigeru Kohno, Mitsuo Kaku.   

Abstract

Efflux systems are thought to contribute to antimicrobial resistance in Pseudomonas aeruginosa. The mexAB-oprM deletion strain of P. aeruginosa PAO1 is compromised in its capacity to invade Madin-Darby canine kidney (MDCK) cells, suggesting that P. aeruginosa exports invasion determinants using a MexAB-OprM system. The influences of efflux pump inhibitors (EPIs), including the broad-spectrum EPI Phe-Arg-beta-naphthylamide (PAbetaN) and MexAB-OprM-specific EPI D13-9001, on the invasion of wild-type (WT) P. aeruginosa PAO1 and its MexAB-OprM-overproducing nalB strain were examined. The invasiveness of PAO1 WT and nalB strains was inhibited in the presence of EPIs in a concentration-dependent manner. Reduction of the invasiveness of both strains was greater for D13-9001 compared with PAbetaN. EPIs are thought to be useful in reducing the invasiveness and antimicrobial resistance of P. aeruginosa and thus may be promising as new anti-infectious agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615866     DOI: 10.1016/j.ijantimicag.2009.06.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  24 in total

1.  Listeria monocytogenes strain-specific impairment of the TetR regulator underlies the drastic increase in cyclic di-AMP secretion and beta interferon-inducing ability.

Authors:  Takeshi Yamamoto; Hideki Hara; Kohsuke Tsuchiya; Shunsuke Sakai; Rendong Fang; Motohiro Matsuura; Takamasa Nomura; Fumihiko Sato; Masao Mitsuyama; Ikuo Kawamura
Journal:  Infect Immun       Date:  2012-04-16       Impact factor: 3.441

Review 2.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 3.  The hydrophobic trap-the Achilles heel of RND efflux pumps.

Authors:  Zachary Aron; Timothy J Opperman
Journal:  Res Microbiol       Date:  2017-11-13       Impact factor: 3.992

Review 4.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

5.  Possible Role of Curcumin as an Efflux Pump Inhibitor in Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa.

Authors:  Nidhi Negi; Pradyot Prakash; Mohan Lal Gupta; Tribhuban Mohan Mohapatra
Journal:  J Clin Diagn Res       Date:  2014-10-20

Review 6.  Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.

Authors:  Ronit Vogt Sionov; Doron Steinberg
Journal:  Microorganisms       Date:  2022-06-16

7.  ToxR Mediates the Antivirulence Activity of Phenyl-Arginine-β-Naphthylamide To Attenuate Vibrio cholerae Virulence.

Authors:  Yuding Weng; Thomas F Bina; X Renee Bina; James E Bina
Journal:  Infect Immun       Date:  2021-06-16       Impact factor: 3.441

8.  Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa.

Authors:  Momen Askoura; Walid Mottawea; Turki Abujamel; Ibrahim Taher
Journal:  Libyan J Med       Date:  2011-05-13       Impact factor: 1.657

9.  Metallacarborane Derivatives Effective against Pseudomonas aeruginosa and Yersinia enterocolitica.

Authors:  Wieslaw Swietnicki; Waldemar Goldeman; Mateusz Psurski; Anna Nasulewicz-Goldeman; Anna Boguszewska-Czubara; Marek Drab; Jordan Sycz; Tomasz M Goszczyński
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

10.  The intrinsic resistome of bacterial pathogens.

Authors:  Jorge Olivares; Alejandra Bernardini; Guillermo Garcia-Leon; Fernando Corona; Maria B Sanchez; Jose L Martinez
Journal:  Front Microbiol       Date:  2013-04-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.